Resverlogix Corp. (TSE:RVX – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.10 and traded as high as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 117,000 shares changing hands.
Resverlogix Price Performance
The company has a quick ratio of 0.04, a current ratio of 0.03 and a debt-to-equity ratio of -83.11. The business has a 50-day moving average price of C$0.10 and a two-hundred day moving average price of C$0.10. The company has a market capitalization of C$30.11 million, a price-to-earnings ratio of -4.75 and a beta of 0.41.
Resverlogix (TSE:RVX – Get Free Report) last issued its earnings results on Friday, May 15th. The biotechnology company reported C$0.01 earnings per share (EPS) for the quarter. As a group, research analysts anticipate that Resverlogix Corp. will post -0.22 EPS for the current year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Further Reading
- Five stocks we like better than Resverlogix
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
